Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$2.08M Buy
12,459
+1,539
+14% +$260K 0.26% 70
2016
Q2
$1.66M Buy
10,920
+346
+3% +$53.8K 0.22% 89
2016
Q1
$1.58M Buy
10,574
+658
+7% +$97.8K 0.22% 94
2015
Q4
$1.61M Buy
9,916
+557
+6% +$87.6K 0.22% 99
2015
Q3
$1.29M Buy
9,359
+97
+1% +$15.3K 0.19% 105
2015
Q2
$1.42M Sell
9,262
-18
-0.2% -$2.88K 0.23% 100
2015
Q1
$1.48M Buy
9,280
+120
+1% +$18.9K 0.24% 90
2014
Q4
$1.46M Buy
9,160
+205
+2% +$31.9K 0.24% 89
2014
Q3
$1.26M Sell
8,955
-8,791
-50% -$1.15M 0.22% 84
2014
Q2
$2.1M Buy
17,746
+53
+0.3% +$6.13K 0.4% 46
2014
Q1
$2.18M Sell
17,693
-17,563
-50% -$2.13M 0.44% 42
2013
Q4
$18M Buy
35,256
+17,763
+102% +$2.02M 0.67% 38
2013
Q3
$1.96M Buy
17,493
+46
+0.3% +$4.99K 0.42% 34
2013
Q2
$1.72M Buy
+17,447
New +$1.81M 0.41% 34

Other funds holding AMGN

Gerstein Fisher's AMGN Position: Q3 2016 in Review

Gerstein Fisher increased its Amgen (AMGN) stake by 14% in Q3 2016, buying an estimated $260K and bringing the position to 12,459 shares worth $2.08M. The position accounts for 0.26% of the portfolio, ranked #70.

Gerstein Fisher first reported a position in AMGN in Q2 2013 and has held it in 14 quarters since. The position peaked at $18M in Q4 2013. 1,518 funds tracked by Wall St. Rank hold AMGN as of Q3 2016.

  • Gerstein Fisher held 12,459 shares of Amgen worth $2.08M as of Q3 2016.
  • Gerstein Fisher bought 1,539 Amgen shares in Q3 2016, an estimated $260K.
  • Amgen made up 0.26% of Gerstein Fisher's portfolio in Q3 2016, its #70 holding.
  • Gerstein Fisher first reported a position in Amgen in Q2 2013 and has held it in 14 quarters since.
  • Gerstein Fisher's Amgen position peaked at $18M in Q4 2013.
  • 1,518 funds tracked by Wall St. Rank held Amgen as of Q3 2016.

Based on Gerstein Fisher's 13F filing for Q3 2016, filed 15 Nov 2016.